GE HealthCare CEO sold shares, institutional investors increased stakes, and earnings exceeded estimates.

In Q3, GE HealthCare Technologies Inc. (NASDAQ: GEHC) experienced notable stock activity. CEO Thomas J. Westrick sold 2,750 shares, while institutional investors like Vanguard and Capital Research increased their stakes. The company reported earnings of $1.00 per share, surpassing estimates, and holds a market cap of $40.76 billion. Analysts generally rate the stock as a "Moderate Buy" with a consensus price target of $94.23.